We have observed that the chemokine modulatory effects of CKM depend on canonical NF-κB signaling and selectively target tumor tissues over healthy tissues due to the hyperactivation of the canonical NF-κB pathway in the stromal and myeloid cells of the TME (12, 17). Here, NFKB1 is linked to neoplasm.